Cell Viability Assays Market- Roadmap for Recovery From COVID-19 | Focus On Timely Diagnosis Of Diseases to Boost the Market Growth
LONDON–(BUSINESS WIRE)–Sep 25, 2020– Technavio has been monitoring the cell viability assays market and it…
LONDON–(BUSINESS WIRE)–Sep 25, 2020–
Technavio has been monitoring the cell viability assays market and it is poised to grow by USD 1.40 bn during 2020-2024, progressing at a CAGR of over 8% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200925005277/en/
Technavio has announced its latest market research report titled Global Cell Viability Assays Market 2020-2024 (Graphic: Business Wire)
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio’s in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts
Frequently Asked Questions:
- What are the major trends in the market?
Growing focus on stem cell research is a major trend driving the growth of the market.
- At what rate is the market projected to grow?
The year-over-year growth for 2020 is estimated at 8.06% and the incremental growth of the market is anticipated to be $ 1.40 bn.
- Who are the top players in the market?
Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Biotium Inc., Danaher Corp., General Electric Co., Merck KGaA, PerkinElmer Inc., Promega Corp., and Thermo Fisher Scientific Inc., are some of the major market participants.
- What is the key market driver?
The focus on timely diagnosis of diseases is one of the major factors driving the market.
- How big is the Europe market?
The Europe region will contribute 30% of the market share.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Agilent Technologies Inc., Becton, Dickinson and Co., Bio-Rad Laboratories Inc., Biotium Inc., Danaher Corp., General Electric Co., Merck KGaA, PerkinElmer Inc., Promega Corp., and Thermo Fisher Scientific Inc. are some of the major market participants. The focus on timely diagnosis of diseases will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Technavio’s custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Cell Viability Assays Market 2020-2024: Segmentation
Cell Viability Assays Market is segmented as below:
- Geographic Landscape
- North America
- South America
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40302
Cell Viability Assays Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The cell viability assays market report covers the following areas:
- Cell Viability Assays Market Size
- Cell Viability Assays Market Trends
- Cell Viability Assays Market Industry Analysis
This study identifies growing focus on stem cell research as one of the prime reasons driving the cell viability assays market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio’s SUBSCRIPTION platform
Cell Viability Assays Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist cell viability assays market growth during the next five years
- Estimation of the cell viability assays market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the cell viability assays market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of cell viability assays market vendors
Table of Contents:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Value chain analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2019
- Market size and forecast 2019-2024
- Market outlook
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Consumables – Market size and forecast 2019-2024
- Instruments – Market size and forecast 2019-2024
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2019-2024
- Europe – Market size and forecast 2019-2024
- Asia – Market size and forecast 2019-2024
- ROW – Market size and forecast 2019-2024
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Growing focus on stem cell research
- Application in drug discovery process
- Increasing healthcare expenditure
PART 12: VENDOR LANDSCAPE
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Agilent Technologies Inc.
- Becton, Dickinson and Co.
- Bio-Rad Laboratories Inc.
- Biotium Inc.
- Danaher Corp.
- General Electric Co.
- Merck KGaA
- PerkinElmer Inc.
- Promega Corp.
- Thermo Fisher Scientific Inc.
PART 14: APPENDIX
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200925005277/en/
CONTACT: Technavio Research
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
INDUSTRY KEYWORD: HEALTH STEM CELLS
SOURCE: Technavio Research
Copyright Business Wire 2020.
PUB: 09/25/2020 03:30 PM/DISC: 09/25/2020 03:30 PM